StockData
IRIDEX Corp logo

IRIDEX Corp (IRIX) stock

IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 17, 2026Score 7/30
$0.70+0.01 (+1.72%)

Close on Nov 17, 2026Market cap $12.29MP/E –Yield –

Iridex r&d expenses

Research and development expenses are spending on new products and technology.

Iridex's R&D Expenses for the twelve months ending Oct 3, 2026 was $3.80M, down 0.7% year over year. For fiscal 2025 it was $3.67M, down 32.7% from the year before. Over ten years it grew -3.5% a year on average. The highest annual figure on record is $7.18M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Jan 3, 2026$3.67M-32.7%
FY2024Dec 28, 2024$5.45M-20.2%
FY2023Dec 30, 2023$6.83M-4.8%
FY2022Dec 31, 2022$7.18M+4.5%
FY2021Jan 1, 2022$6.87M+109.3%
FY2020Jan 2, 2021$3.28M-10.9%
FY2019Dec 28, 2019$3.68M-8.1%
FY2018Dec 29, 2018$4.01M-23.1%
FY2017Dec 30, 2017$5.21M-2.9%
FY2016Dec 31, 2016$5.37M+2.9%
FY2015Jan 2, 2016$5.21M+12.6%
FY2014Jan 3, 2015$4.63M+25.7%
FY2013Dec 28, 2013$3.68M-16.0%
FY2012Dec 29, 2012$4.39M+12.1%
FY2011Dec 31, 2011$3.91M+4.3%
FY2010Jan 1, 2011$3.75M+13.2%
FY2009Jan 2, 2010$3.32M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Oct 3, 2026$1.01M+4.3%
Q2 FY2026Jul 4, 2026$936.00K+7.5%
Q1 FY2026Apr 4, 2026$905.00K+3.3%
Q4 FY2025Jan 3, 2026$949.00K-14.7%
Q3 FY2025Sep 27, 2025$972.00K-25.2%
Q2 FY2025Jun 28, 2025$871.00K-42.0%
Q1 FY2025Mar 29, 2025$876.00K-43.0%
Q4 FY2024Dec 28, 2024$1.11M-34.3%
Q3 FY2024Sep 28, 2024$1.30M-15.7%
Q2 FY2024Jun 29, 2024$1.50M-18.6%
Q1 FY2024Mar 30, 2024$1.54M-12.2%
Q4 FY2023Dec 30, 2023$1.69M+16.8%
Q3 FY2023Sep 30, 2023$1.54M-8.7%
Q2 FY2023Jul 1, 2023$1.85M-4.0%
Q1 FY2023Apr 1, 2023$1.75M-17.3%
Q4 FY2022Dec 31, 2022$1.45M-35.4%
Q3 FY2022Oct 1, 2022$1.69M-5.6%
Q2 FY2022Jul 2, 2022$1.92M+15.0%
Q1 FY2022Apr 2, 2022$2.12M+81.6%
Q4 FY2021Jan 1, 2022$2.24M+152.9%
Q3 FY2021Oct 2, 2021$1.79M+105.8%
Q2 FY2021Jul 3, 2021$1.67M+107.2%
Q1 FY2021Apr 3, 2021$1.17M+62.0%
Q4 FY2020Jan 2, 2021$887.00K+12.6%
Q3 FY2020Sep 26, 2020$869.00K-13.7%
Q2 FY2020Jun 27, 2020$807.00K-13.1%
Q1 FY2020Mar 28, 2020$719.00K-24.9%
Q4 FY2019Dec 28, 2019$788.00K-7.5%
Q3 FY2019Sep 28, 2019$1.01M-12.4%
Q2 FY2019Jun 29, 2019$929.00K+3.1%
Q1 FY2019Mar 30, 2019$958.00K-13.2%
Q4 FY2018Dec 29, 2018$852.00K-33.3%
Q3 FY2018Sep 29, 2018$1.15M-13.0%
Q2 FY2018Jun 30, 2018$901.00K-34.2%
Q1 FY2018Mar 31, 2018$1.10M-17.6%
Q4 FY2017Dec 30, 2017$1.28M-5.9%
Q3 FY2017Sep 30, 2017$1.32M–
Q2 FY2017Jul 1, 2017$1.37M–
Q1 FY2017Apr 1, 2017$1.34M–
Q4 FY2016Dec 31, 2016$1.36M–

More Iridex figures

See a number that looks wrong?